
### [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875)
**Label:** Li-Fraumeni syndrome

**Subclasses:** [MONDO:0012234](http://purl.obolibrary.org/obo/MONDO_0012234) (LFS3), [MONDO:0012233](http://purl.obolibrary.org/obo/MONDO_0012233) (Li-Fraumeni syndrome 2), [MONDO:0007903](http://purl.obolibrary.org/obo/MONDO_0007903) (Li-Fraumeni syndrome 1), 

**Corr. equiv. classes:** [OMIM:151623](http://purl.obolibrary.org/obo/OMIM_151623), [OMIM:609265](http://purl.obolibrary.org/obo/OMIM_609265), [OMIM:609266](http://purl.obolibrary.org/obo/OMIM_609266), 

**Class expressions from DL-Learner:**

- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100787](http://purl.obolibrary.org/obo/HP_0100787) (Prostate neoplasm) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100641](http://purl.obolibrary.org/obo/HP_0100641) (Neoplasm of the adrenal cortex) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100273](http://purl.obolibrary.org/obo/HP_0100273) (Neoplasm of the colon) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 66.67%
- [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) and [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) 66.67%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0012125](http://purl.obolibrary.org/obo/HP_0012125) (Prostate cancer) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%
- [HP:0010935](http://purl.obolibrary.org/obo/HP_0010935) (Abnormality of the upper urinary tract) and [HP:0030078](http://purl.obolibrary.org/obo/HP_0030078) (Lung adenocarcinoma) 66.67%


